Products

InferRead Lung CT.AI
Infervision
Oncology AI
InferRead Lung CT.AI by Infervision is an AI-powered tool designed to assist radiologists in detecting, quantifying, and classifying pulmonary nodules from chest CT scans, enhancing diagnostic accuracy and efficiency for lung cancer screening and diagnosis.
InferRead CT Stroke.AI
InferVision
Neurology AI
InferRead CT Stroke.AI is an AI-powered software by Infervision Medical Technology Co. designed to prioritize head CT scans by flagging suspected intracranial hemorrhage (ICH) cases, aiding radiologists in faster triage and improved workflow efficiency.
InferOperate Suite
Infervision
Oncology AI
InferOperate Suite is an AI-powered medical imaging software by Infervision, offering automated 3D reconstruction, visualization, and comprehensive surgical planning tools for various procedures, including those for lung, liver, and kidney tumors.

See all 3 products →

About Infervision

Infervision is a pioneering AI medical technology company established in 2016, dedicated to advancing multidisciplinary healthcare services through artificial intelligence. The company focuses on three critical areas: disease screening and diagnosis, patient treatment and management, and research and development. Infervision’s comprehensive suite of AI-driven software aims to enhance operational efficiency and patient outcomes across a broad spectrum of medical needs.

For physicians, Infervision offers cutting-edge AI products that support medical professionals throughout the patient journey. This includes solutions for disease screening and diagnosis (InferRead®), interventional support and treatment (InferOperate®), patient health management (InferCare®), and medical education and research (InferScholar®, InferMatrix, InferEducate). Their AI-assisted software is designed to detect a wide range of anomalies, such as cancers, infectious diseases, cardiovascular conditions, cerebrovascular diseases, and trauma. Infervision’s products are integrated into clinical workflows and are relied upon globally, with partnerships spanning over 1000 hospitals across North America, Europe, and Asia.

Focus Areas

medical imaging analysis disease screening diagnosis interventional support treatment planning patient management medical education medical research oncology cardiology cerebrovascular diseases pulmonary nodules pneumonia tuberculosis fractures

Business Intelligence

TechnologyAI-powered deep learning algorithms, cloud-native, edge computing, 5G mobile stroke unit, MONAI framework, TensorRT-accelerated inference

What Physicians Need to Know

Medical Imaging Analysis
Infervision offers AI-powered solutions for comprehensive medical imaging analysis across various modalities like CT and X-ray. Their InferRead® suite assists in detecting abnormalities in chest X-rays and CT scans, including lung nodules, pneumonia, tuberculosis, and fractures. They also provide solutions for coronary artery stenosis detection in CT angiograms and intracranial hemorrhage detection and quantification in brain CTs.
Disease Screening & Diagnosis
The company specializes in AI-assisted screening and diagnosis for a wide range of conditions, including cancers, infectious diseases (like pneumonia and tuberculosis), cardiovascular diseases, cerebrovascular diseases (strokes), and trauma. Their products aim to improve diagnostic accuracy and efficiency, for example, by identifying suspected pneumonia cases in less than a minute or aiding in early-stage lung cancer diagnosis.
Interventional Support & Treatment Planning
Infervision's InferOperate® suite provides automated 3D reconstruction for surgical planning across multiple organs, including the thorax, liver, and urology. These tools offer high-precision anatomical segmentation, preoperative planning, and interactive visualization to enhance patient safety and support multidisciplinary team discussions.
Patient Management
InferCare® is Infervision's intelligent platform designed for tumor imaging follow-up and therapeutic response evaluation. It supports multi-organ, multi-time-point, and multi-dimensional lesion tracking and analysis, generating automated structured reports for consistent radiologic assessment.
Medical Education & Research
Infervision supports medical education and research through platforms like InferScholar® and InferMatrix. InferMatrix is an AI-enabled medical application platform designed to bridge the gap between research and application by integrating algorithms into user-friendly software.
Oncology
Infervision offers solutions for lung cancer screening and follow-up, including lung nodule detection and multi-dimensional lesion analysis for tumor progression or treatment response. Their InferCare RECIST platform provides systematic support for oncology MDTs and neoadjuvant therapy assessment.
Cardiology & Cerebrovascular Diseases
The company provides AI for coronary CT angiography to evaluate coronary artery stenosis, improving diagnostic precision and reducing reading times. For cerebrovascular diseases, their solutions offer fast identification and alerts for suspected intracranial hemorrhage and aid in stroke management, including a 5G mobile stroke unit for on-site diagnosis and treatment.
Pulmonary Nodules, Pneumonia, Tuberculosis, Fractures
Infervision has specific AI solutions for detecting and analyzing pulmonary nodules from chest CTs, identifying and triaging pneumonia from chest CTs, detecting tuberculosis from chest X-rays, and identifying chest fractures from chest CTs.
Physician Tip

Infervision's AI solutions are designed to empower physicians with increased efficiency and accuracy in diagnosis, treatment planning, and patient management. Their tools can significantly reduce reading times for complex scans, provide automated measurements and structured reports, and offer cross-timepoint comparisons for disease progression, which can be invaluable for oncology and chronic disease management. The ability to perform automated 3D reconstructions and surgical simulations can enhance preoperative planning and patient safety. Furthermore, the integration with existing hospital systems (DICOM and HL7) ensures a seamless workflow.

Infervision's products are designed for deep integration with hospital systems, supporting standards such as DICOM and HL7 for cross-campus data management. They have also established collaborations with global tech leaders like Microsoft and NVIDIA to enhance their AI development and deployment, including integration into the Microsoft Precision Imaging Network. Their solutions are compatible with both on-premise and cloud-based environments.

Products by Infervision

3 products in the directory

InferRead Lung CT.AI
Infervision
Oncology AI
InferRead Lung CT.AI by Infervision is an AI-powered tool designed to assist radiologists in detecting, quantifying, and classifying pulmonary nodules from chest CT scans, enhancing diagnostic accuracy and efficiency for lung cancer screening and diagnosis.
InferRead CT Stroke.AI
InferVision
Neurology AI
InferRead CT Stroke.AI is an AI-powered software by Infervision Medical Technology Co. designed to prioritize head CT scans by flagging suspected intracranial hemorrhage (ICH) cases, aiding radiologists in faster triage and improved workflow efficiency.
InferOperate Suite
Infervision
Oncology AI
InferOperate Suite is an AI-powered medical imaging software by Infervision, offering automated 3D reconstruction, visualization, and comprehensive surgical planning tools for various procedures, including those for lung, liver, and kidney tumors.

What the Web Says

Infervision is an AI medical technology company that focuses on applying artificial intelligence and deep learning to healthcare, particularly in medical imaging analysis and diagnostics. Their products, such as InferRead Lung CT.AI and InferRead DR Chest, are designed to assist healthcare professionals in detecting diseases like lung nodules and tuberculosis, aiming to improve diagnostic accuracy and efficiency. The company's solutions are used in numerous hospitals and imaging centers globally, processing a significant number of cases daily. While there is extensive information on their products and partnerships, direct employee or comprehensive product reviews on platforms like G2, Glassdoor, Capterra, or Reddit are limited or not readily available under the name 'Infervision'.

Overall: Positive

Strengths

  • Advanced AI for real-time imaging analysis and diagnostics
  • Automated lesion detection and early disease identification
  • Improved diagnostic accuracy and reduced reading times for medical professionals
  • FDA clearance and CE mark for key products like InferRead Lung CT.AI
  • Global presence and significant daily case processing
  • Integration with existing medical workflows

Limitations

  • Limited readily available direct product reviews on major platforms (G2, Capterra)
  • Scarcity of employee reviews on platforms like Glassdoor or Indeed specifically for 'Infervision'
  • No significant discussions or reviews found on Reddit regarding Infervision's products or as an employer
  • Some search results for 'Infervision' on review sites like G2 and Capterra appear to be for different companies (e.g., InVision, InfoCision)

Based on reviews from: AI.cc, Slashdot, Infervision News and Events, Facebook (Infervision Technology)

Last updated: 2026-10-17

Videos

News, demos, and interviews about Infervision.

Loading videos...

Videos load interactively. If none appear, search YouTube for Infervision →

View all on YouTube

Press & Coverage

Infervision
Infervision Receives FDA Clearance of InferOperate Suite
Infervision received FDA 510(k) clearance for its InferOperate Suite, an AI-powered surgical planning solution, making it the first such solution cleared in the US, EU, UK, and China. This suite automates 3D model generation for organs and vascular structures, aiding in preoperative planning and intraoperative guidance, particularly for complex tumor surgeries.
2025-09
Infervision
Leading the Future of Medical Imaging: InferVision Showcases Global-Ready AI Innovations at RSNA 2025
InferVision showcased new breakthroughs in surgical planning, oncology assessment, and global ecosystem collaboration at RSNA 2025, reaffirming its leadership in AI healthcare. The company's InferOperate automatic 3D reconstruction products achieved regulatory milestones with CE, UKCA, and FDA clearances, expanding global accessibility.
2025-12
Infervision
Infervision Receives FDA 510(k) Clearance for Enhanced Features in InferRead CT Lung
Infervision's InferRead® Lung CT.AI received FDA 510(k) clearance for enhanced features, including automated detection of nodules as small as 4mm and expanded structured assessments of clinical parameters. This strengthens Infervision's position in AI-driven lung nodule detection for lung cancer screening and diagnosis.
2025-05
Infervision
InferVision has received U.S. Food and Drug Administration (FDA) clearance for InferCare RECIST, bringing AI-powered, standardized tumor assessment into routine oncology workflows.
InferVision received FDA clearance for InferCare RECIST, an AI-powered solution for standardized tumor assessment in oncology workflows. This software automates lesion measurement and longitudinal tracking, streamlining workflows and reducing variability in clinical practice.
2026-03
Viz.ai
Viz.ai and Infervision Partner on AI Solution to Aid in Earlier Detection and Clinical Workup of Lung Cancer
Viz.ai partnered with Infervision to integrate InferRead Lung CT.AI, an FDA-cleared AI solution for lung nodule detection, into the Viz.ai ecosystem. This collaboration aims to improve early detection and clinical workup of lung cancer, providing detailed analytical information to assist clinicians.
2024-04
Infervision
Infervision's AI Solutions for Chest, Brain, and Heart Secure CE and UKCA Certifications
Infervision's AI-assisted diagnostic solutions for chest, brain, and heart, covering indications like pulmonary nodules, pneumonia, intracranial hemorrhage, and coronary artery disease, achieved dual CE and UKCA certifications. This expands Infervision's presence in European and UK markets, adding to its existing FDA, PMDA, and NMPA approvals.
2024-08
Infervision
AI-based chest CT semantic segmentation algorithm enables semi-automated lung cancer surgery planning by recognizing anatomical variants of pulmonary vessels
A study published by Infervision researchers demonstrated an AI-based chest CT semantic segmentation algorithm that enables semi-automated lung cancer surgery planning. The AI model showed an overall case-wise accuracy of 82.8% in pulmonary vessels, comparable to junior thoracic surgery attendings.
2025-07
Private Equity Insights
InferVision raised $140m Led by Goldman Sachs Asset Management
InferVision completed its Series D2 financing round, raising approximately $140 million, led by Goldman Sachs Asset Management. The funds will be allocated towards R&D, expansion of distribution channels, and business development to further its AI-powered detection and triage systems.
2021-07

Frequently Asked Questions

Infervision provides AI-powered medical imaging analysis solutions across various specialties, including oncology (e.g., lung nodule detection and characterization), cardiology (e.g., coronary artery disease assessment), and cerebrovascular diseases (e.g., stroke triage). Their products assist with disease screening, diagnosis, and treatment planning by enhancing the speed and accuracy of image interpretation.
Infervision's AI algorithms are developed and validated using large datasets and rigorous testing protocols to ensure high accuracy and reliability. They often collaborate with leading medical institutions and publish their findings to demonstrate clinical efficacy and address critical concerns in areas like pulmonary nodules, pneumonia, tuberculosis, and fracture diagnosis.
Infervision is committed to regulatory compliance and holds relevant certifications for its medical AI products in various regions. They adhere to data privacy regulations such as HIPAA and GDPR and have obtained necessary medical device approvals from authorities like the NMPA in China and CE marking in Europe, ensuring their products meet stringent safety and performance standards.
Infervision's pricing structure typically varies based on the specific solutions implemented, the scale of deployment, and the modules chosen. They generally offer comprehensive support and maintenance packages that include technical assistance, software updates, and performance monitoring to ensure optimal operation and user satisfaction.
Infervision's platforms are designed for seamless integration with existing hospital IT infrastructure, including PACS, EMR, and other healthcare systems. They utilize standard protocols like DICOM and HL7 to ensure smooth data exchange and minimize disruption to current clinical workflows, facilitating efficient adoption and utilization.
Infervision has a strong track record in the medical AI field, demonstrating significant growth and innovation. They have established notable partnerships with numerous hospitals, research institutions, and technology companies globally, underscoring their long-term viability and commitment to advancing healthcare through AI.
Infervision's AI assists with interventional support by providing real-time analysis and guidance during procedures, enhancing precision and safety. For treatment planning, it offers data-driven insights to personalize patient care. Additionally, their platforms can be utilized in medical education for training purposes and in patient management to monitor disease progression and treatment response.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.